Bixiye
Ophthalmic Prostaglandins - Medicaid
Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2025
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1011 - 1020 ee natiijooyinka 3604
Bixiye
Urinary Incontinence - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
Skyclarys (omaveloxolone) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2025
Bixiye
Ophthalmic Pilocarpine - Medicaid
Quantity Limit
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2025
Bixiye
Daybue (trofinetide) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
Antiretroviral - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
QP71-23 Register for Webinar | Trauma-Informed Care 102 | Tuesday, September 28, 5-6:30 pm
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
QP72-23 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective November 1, 2023
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
QP73-23 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2023
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023
Bixiye
QP74-23 Commercial Pharmacy Benefit Exclusion for Abilify Asimtufii®, Adstiladrin®, Brixadi™, Glydo®, lidocaine 2%, Roctavian™, and Uzedy™
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 13, 2023